Table 1.
Baseline characteristics of participants.
| Characteristic | All participants (n=30) | Retained participants (n=16) | |
| Age (years), median (IQR) | 62 (54.1-70.2) | 62 (54.9-67.5) | |
| BMI (kg/m2), median (IQR) | 24.5 (21.9-29.8) | 23 (20.8-34.6) | |
| Gender, n (%) | |||
|
|
Man | 3 (10) | 2 (13) |
|
|
Woman | 26 (87) | 13 (81) |
|
|
Prefer not to answer | 1 (3) | 1 (6) |
| Race, n (%) | |||
|
|
Asian population | 1 (3) | 1 (6) |
|
|
White population | 28 (93) | 15 (94) |
|
|
Prefer not to identify | 1 (3) | 0 (0) |
| Ethnicity, n (%) | |||
|
|
Non-Hispanic or Latino(a) population | 25 (96) | 14 (100) |
|
|
Prefer not to identify | 1 (4) | 0 (0) |
| Language, n (%) | |||
|
|
English | 30 (100) | 16 (100) |
| MPNa diagnosis, n (%) | |||
|
|
Essential thrombocytosis | 11 (37) | 7 (44) |
|
|
Polycythemia vera | 11 (37) | 5 (31) |
|
|
Myelofibrosis | 8 (27) | 4 (25) |
| Year of MPN diagnosis, n (%) | |||
|
|
2015 to present | 7 (24) | 4 (27) |
|
|
2010-2014 | 13 (45) | 6 (40) |
|
|
Before 2010 | 9 (31) | 5 (33) |
| History of enlarged spleen, n (%) | 11 (37) | 6 (38) | |
| History of anemia, n (%) | 12 (40) | 4 (25) | |
aMPN: myeloproliferative neoplasm.